Literature DB >> 2298084

Successful treatment of sarcoidosis-associated pulmonary hypertension with corticosteroids.

D M Rodman1, J Lindenfeld.   

Abstract

We report a case of sarcoidosis presenting with cor pulmonale of a greater severity than would be expected from the degree of hypoxia and pulmonary fibrosis. Right heart catheterization revealed that mean pulmonary artery pressure was markedly increased (42 mm Hg), was not reduced by supplemental oxygen, but was reduced significantly (25 mm Hg) after 16 weeks of therapy with corticosteroids. Improvement in symptoms and pulmonary function was maintained for an 18-month period of observation after cessation of corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298084     DOI: 10.1378/chest.97.2.500

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.

Authors:  H Nunes; M Humbert; F Capron; M Brauner; O Sitbon; J-P Battesti; G Simonneau; D Valeyre
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 2.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

3.  Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients.

Authors:  Esam H Alhamad; Majdy M Idrees; Mohammed O Alanezi; Ahmad A Alboukai; Shaffi Ahmad Shaik
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

Review 4.  [Interstitial lung diseases and pulmonary hypertension].

Authors:  H P Hauber
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

Review 5.  Pulmonary hypertension caused by sarcoidosis.

Authors:  Enrique Diaz-Guzman; Carol Farver; Joseph Parambil; Daniel A Culver
Journal:  Clin Chest Med       Date:  2008-09       Impact factor: 2.878

6.  Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.

Authors:  Christopher F Barnett; Eric J Bonura; Steven D Nathan; Shahzad Ahmad; Oksana A Shlobin; Kwabena Osei; Ari L Zaiman; Paul M Hassoun; David R Moller; Scott D Barnett; Reda E Girgis
Journal:  Chest       Date:  2008-12-31       Impact factor: 9.410

7.  The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis.

Authors:  Mehdi Mirsaeidi; Hesham R Omar; Golnaz Ebrahimi; Micheal Campos
Journal:  Int J Hypertens       Date:  2016-06-28       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.